| Vasogen, Inc., a development stage company, engages in the research and development of immune modulation therapies for chronic inflammation underlying cardiovascular disorders primarily in Canada. Its primary product, Celacade, is in two pivotal phase III clinical trials for the treatment of chronic heart failure and peripheral arterial disease. The company's another product VP025 is in preclinical development for the treatment of neurodegenerative disorders, including Parkinson's and Alzheimer's disease. Vasogen was founded in 1980 and is headquartered in Mississauga, Canada. |
- Premarket, intraday, nightly, and weekend updates, which include stock picks with full instructions, market direction (short, intermediate, long term), precious metal, commodity, and currency analysis.
- Provide you stock picks (breakouts) and market direction to help you become
more profitable.
- Voice over chart updates sent to you by e-mail. These updates contain stock picks and market status for a number of different portfolios, which Trending123 is recommending and following.
- Instantaneous e-mail alerts during the trading day when targets have been hit or the status of a position or the market warrants a move. Stock Recommendations for swing traders, day traders, and long term investors.
- Receive instant emails to your computer, organizer, cell phone of breakouts on stocks.....Learn More
|
|
|
